References
- 1. CORESTA: CD-ROM Version no. 32, September 2011.
- 2. U.S. Department of Health, Education and Welfare, Public Health Service: Smoking and Health, Report of the Advisory Committee to the Surgeon General of the Public Health Service; PHS Publication No. 1103, Washington DC, USA, 1964.
- 3. S.E.I.T.A.: L'acte spécifique du fumeur; CORESTA 2nd Scientific Tobacco Congress, Brussels, Belgium, 1958, abstract 1564.
- 4. Reeves, N. and M. Dixon: The Measurement of Human Smoking Behaviour and the Influence of Changes in Behavioural Parameters on Mainstream Smoke Deliver-ies; CORESTA Joint Meeting Smoke and Technology Groups, Vienna, Austria, 1995, paper ST19.
- 5. Dunn, P.J., M. Youssef, and B. Bentrovato: Variations in Tar, Nicotine and Carbon Monoxide Deliveries Obtained by Smokers of the Same Brand; CORESTA Joint Meeting Smoke and Technology Groups, Vienna, Austria, 1995, paper ST20.
- 6. Borgerding, M.F. and L.S. Winkler: The Effect of Al-ternative Puffing Regimens on Relative Cigarette Performance; CORESTA Joint Meeting Smoke and Technology Groups, Vienna, Austria, 1995, paper ST21.
- 7. Djordjevic, M.V., J. Fan, S. Ferguson, and D. Hoffmann: The Chemical Composition of Mainstream Cigarette Smoke Generated under FTC/CORESTA and Actual Human Smoking (AHS) Conditions; CORESTA Joint Meeting Smoke and Technology Groups, Vienna, Austria, 1995, paper ST22.
- 8. Byrd, G.D., J.H. Robinson, W.S. Caldwell, and J.D. de Bethizy: FTC Yields and Nicotine Uptake in Smokers; CORESTA Joint Meeting Smoke and Technology Groups, Vienna, Austria, 1995, paper ST23. 5 Selected papers as mentioned in the text. Mentioning of any single paper does not necessarily indicate its exclusivity.
- 10. Scherer, G.: Smoking Behaviour and Compensation: A Review of the Literature; Psychopharmacology 145 (1999) 1-20.
- 11. Baker, R.R. and L.S. Lewis: Filter Ventilation - Has There Been a ‘Cover-up’? Rec. Adv. Tob. Sci. 23 (1997) 152-196.
- 12. Scherer, G.: Carboxyhemoglobin and Thiocyanate as Biomarkers of Exposure to Carbon Monoxide and Hydrogen Cyanide in Tobacco Smoke; Exp. Toxicol. Pathol. 58 (2006) 101-24.
- 12. Tricker, A.R.: Biomarkers derived from nicotine and its metabolites: A review; Beitr. Tabakforsch. Int. 22 (2006) 147-175.
- 13. Scherer, G.: Is There Compensation When Switching to Lower Yield Cigarettes? CORESTA Joint Meeting of the Smoke and Technology Study Groups, Innsbruck, Austria, abstract IG1.
- 14. Baker, R.R. and L.S. Lewis: The Truth Uncovered About Filter Vent Blocking; Information Bulletin, CORESTA Congress, Lisbon, Portugal, 2000 p. 48, paper APST4.
- 15. Baker, R.R. and CORESTA Smoking Behaviour Sub Group: Seminars in Tobacco Science - Terms Used for Exposure to Smoke; Beitr. Tabakforsch. Int. 21 (2004) 250.
- 16. St. Charles, F.K., G. Krautter, D.C. Mariner, and S. Appleton: A Comparison of Human Nicotine Dose Estimates From Filter Analysis with Nicotine Metabolites Analysis; CORESTA Congress, Smoke Science and Product Technology Groups, Kyoto, Japan, 2004, paper SS7.
- 17. Nelson, P.R. and S. Burton: Results from CORESTA Yield-in-Use Ring Trial; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Jeju Island, South Korea, 2007, paper SSPT 46.
- 18. Clayton, P.M., T. Verron, and S.K. Prasad: Results of the 2010 CORESTA Part Filter Method Ring Trial; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Graz, Austria, paper ST 28.
- 19. CORESTA Task Force Nicotine Uptake: Final Report July 2009; available at http://www.coresta.org/Reports/ Nicotine-Uptake-TF_Final-Report.pdf (accessed 08 January 2013).
- 20. CORESTA In Vitro Toxicology Task Force: The Rationale and Strategy for Conducting in Vitro Toxicol-ogy Testing of Tobacco Smoke (May 2004); available at http://www.coresta.org/Reports/IVT TF Rationale-IVT-Testing-Tob.-Smoke_Report_Jun04.pdf (accessed 09 January 2013).
- 21. CORESTA In Vitro Toxicology Task Force: Report on Interlaboratory Study of the In Vitro Toxicity of Partic-ulate Matter from Four Cigarettes (Ames, Neutral Red Cytotoxicity and Micronucleus Assays); available at http://www.coresta.org/Reports/IVT_TF_Report_Part iculate_Matter_Tox.pdf (accessed 09 January 2013).
- 22. CORESTA In vitro Toxicology Task Force: In Vitro Exposure of Cells to Smoke at the Air Liquid Interface; available at http://www.coresta.org/Reports/IVT_ TF Report Smoke Air Liquid Interface.pdf (accessed 09 January _ 2013). _ _
- 23. Joza, P., W.S. Rickert, W. Wright, and M.J. Kaiserman: Factors affecting filter tip colour as a measure of mouth level exposure to tobacco smoke constituents; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups Stratford-upon-Avon, UK, 2005, paper SSPT 34.
- 24. Mariner, D.C, M. Ashley, G. Errington, G. Mullard, S.K. Prasad, J. Sheppard, and C.J. Shepperd: Cross-sectional Study of Cigarette Smoke Exposure in Eight Countries; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Aix-en-Pro-vence, France, 2009, paper SSPTPOST 17.
- 25. Kavvadias, D., G. Scherer, M. Urban, C.J. Shepperd, F. Cheung, G. Errington, and M. McEwan: Determination of Tobacco-Specific N-Nitrosamines in Urine of Smok-ers and Non-Smokers; CORESTA Congress, Smoke Science and Product Technology Group, Shanghai, China, paper SSPT47.
- 26. Zhao, G., X. Yang, F. Xie, S. Wang, Q. Yan, and J. Xie: Simultaneous determination of mercapturic acids derived from benzene, 1,3-butadiene, acrolein and crotonaldehyde in human urine; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Aix-en-Provence, France, 2009, paper SSPT 07.
- 27. Scherer, G., K. Sterz, H.W. Hagedorn, and D. Köhler: Urinary S-Phenylmercapturic Acid (Spma) as a Biomarker for Exposure to Benzene; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Aix-en-Provence, France, 2009, paper SSPT 06.
- 28. Smith, C.J., D.W. Bombick, S.C. McKarns, W.T. Morgan, and D.J. Doolittle: Environmental Room Human Physiology Study Using Fresh Diluted Side-stream Cigarette Smoke; CORESTA Congress, Yoko-hama, Japan, 1996, paper APST2.
- 29. Peters, G., T. Pienemann, and W. Röper: Some Observations on Biomarker Study Design to Assess Potentially Reduced Exposure Products; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Aix-en-Provence, France, 2009, paper SSPT 09.
- 30. Proctor, C, C. Shepperd, A. Eldridge, K.G. McAdam, D. Mariner, and I. Meyer: Cigarette Smoke Toxicant Exposure Estimates in Smokers Switched to Reduced Toxicant Prototype Cigarettes; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Graz, Austria, 2011, paper ST 35.
- 31. Okada, K.: Mentholated Cigarettes and Nicotine and Carbon Monoxide Uptake - A Critical Review of the Literature; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Freiburg, Germany, 2003, paper ST 40.
- 32. Nelson, P.R. and P.X. Chen: Menthol smokers have lower mouth level exposure to “tar” and nicotine than non-menthol smokers; CORESTA Congress, Smoke Science and Product Technology Groups, Edinburgh, UK, 2010, paper SSPT36.
- 33. Ward, M.R. and E.O. Gregg: A Strategic Framework for the Assessment of Potential Reduced Exposure Products; CORESTA Congress, Smoke Science and Product Technology Groups, Edinburgh, UK, 2010, paper SSPT01.
- 34. Robinson, J.H., W.S. Pritchard, and P.M. Lippiello: The Other Side of Smoking; CORESTA Congress, Harare, Zimbabwe, 1994, paper APST3.
- 35. Lee, D.W., H.B. Lim, H.O. Sohn, Y.G. Lee, and U.C. Lee: Inhibition of monoamine oxidase B by cigarette smoke and its constituents; CORESTA Congress, Yokohama, Japan, 1996, paper S11.
- 36. Hindmarch, I.: Is Tobacco Smoking An Addiction? CORESTA Congress, Brighton, UK, 1998, Information Bulletin, p. 22-29.
- 37. Robinson, J.H., M.F. Stiles, and R.A. Davis: Do smok- ers smoke simply to achieve a specific concentration of nicotine in the blood? CORESTA Congress, Lisbon, Portugal, 2000, paper ST28.
- 38. Sherwood, N.: The Human Psychopharmacology of Nicotine; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Freiburg, Germany, 2003, paper IG 01
- 39. Warburton, D.: Psychopharmacology of Smoking and Nicotine; CORESTA Congress, Plenary Session, Kyoto, Japan, 2004, Invited Paper 1.
- 40. Warburton, D.M. and N. Sherwood: Some Psychologi-cal Determinants of Tobacco Use; CORESTA Congress, Smoke Science and Product Technology Groups, Paris, France, 2006, paper SS03.
- 41. Sherwood, N.: The ‘Attractiveness’ and ‘Addictiveness’ of Ingredients Added to Tobacco Products; CORESTA Congress, Plenary Session, Edinburgh, UK, 2010, paper IG01.
- 42. Green, Ch.R. and A. Rodgman: Toxic Chemicals in Cigarette Mainstream Smoke - Hazard and Hoopla; CORESTA Congress, Plenary Session, New Orleans, USA, 2002, Invited Paper.
- 43. Massey, E.D., C. Meredith, and F. Cunningham: Developing risk assessment paradigms for tobacco smoke constituents; CORESTA Congress, Plenary Session, Shanghai, China, 2008, paper IG02.
- 44. Simmons, W.S.: Lung Cancer Risk as a Function of Cigarette Design: Filtration, Blend and Yield; CORESTA Congress, Plenary Session, New Orleans, USA, 2002, Invited Paper.
- 45. Wilson, CL., R.J. Potts, G.R. Krautter, J.A. Bodnar, M.F. Borgerding, and CD. Garner: Development of A Risk-based Priority Toxicant List for Smokeless Tobacco Products; CORESTA Congress, Smoke Science and Product Technology Groups, Shanghai, China, 2008, paper SSPT02.
- 46. Di Muro, A., C. Sorrentino, L. Del Piano, M. Abet, L. Barbato, A. Cuciniello, E. Cozzolino and P. Lombardi: Smoke Condensate Mutagenicity in Several Tobacco Types: Preliminary Study by Sister Chromatid Ex-changes; CORESTA Joint Meeting Agronomy and Phytopathology Study Groups, Suzhou, China, 1999, Poster 15.
- 47.Röper, W. and R. Wieczorek: Strategies to Assess the Biological Properties of Tobacco Smoke; CORESTA Congress, Lisbon, Portugal, 2000, paper ST19, Information Bulletin, p.164.
- 48. Doolittle D.J., D.W. Bombick, C.J. Smith, and B.R. Bombick: the Effect of Cigarette Design on in Vitro Toxicity; CORESTA Congress, Joint Meeting Agronomy and Phytopathology Study Groups, New Orleans, USA, 2002, paper APST5.
- 49. Kalirai, K., J. Whittle, R. Cowin, A. Clack, R. Langford, and E.D. Massey: the Effect of Cigarette Design Variables on Assays of Interest to the Tobacco Industry: - 4) In Vitro Genotoxic Activity of Mainstream Cigarette Smoke; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups Stratford-upon-Avon, UK, 2005, paper SSPT 04.
- 50. Troude, V., S. Achard, S. Destruhaut, C. Haond, and J. Sarabia: Influence of the Origin of the Cigarette Paper Cellulose on the Smoke Chemical Composition and ‘In Vitro’ Toxicity Tests on Mainstream Cigarette Smoke; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Jeju Island, South Korea, 2007, paper SSPT 07.
- 51. Wieczorek, R. and W. Röper: The effect of puff volume on in vitro toxicity of mainstream cigarette smoke; CORESTA Congress, Smoke Science and Product Technology Groups, Edinburgh, UK, 2010, paper SSPT32.
- 52. Massey, E.D., K.K. Kalirai, and G. Smith: In Vitro Genotoxicity of Smoke From Cigarettes Containing Tobacco Ingredients; CORESTA Congress, Smoke Science and Product Technology Groups, New Orleans, USA, 2002, paper ST6.
- 53. Baker, R.R., E.D. Massey, and G. Smith: An Overview of the Effects of Tobacco Ingredients on Smoke Chem-istry and Toxicity; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Freiburg, Germany, 2003, paper ST 16.
- 54. Yao, J.H., R. Cai, H.M. Chen, and CM. Ni: Studies on Chemistry and Mutagenicity of Cigarette Smoke Condensate From Cigarettes Containing the Natural Plant Extract AML-1 Added to the Tobacco; Bull. Spec. CORESTA Congress, Brighton, UK, 1998, paper ST22, Information Bulletin p. 170,
- 55. Shin, H.J., H.O. Sohn, J.H. Han, J.Y. Hur, D.W. Lee and H.C Hyun: Effect of Cigarette Filters on the in Vitro Toxicity of Mainstream Smoke; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups Stratford-upon-Avon, UK, 2005, paper SSPT 26.
- 56. Doolittle, D.J., D.W. Bombick and B.R. Bombick: The Use of in Vitro Short Term Tests to Evaluate Progress Toward Reducing the Toxicity of Cigarette Smoke; CORESTA Joint Meeting Smoke and Technology Study Groups, Xian, China, 2001, paper ST4.
- 57. Wieczorek, R. and W. Röper: Comparison of in Vitro Smoke Toxicity of Novel Charcoal Filter Cigarettes and Benchmark Cigarettes From the UK Market; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Aix-en-Provence, France, 2009, paper SSPT 42.
- 58. Fukushima, T., Y. Miura, Y. Otsu, and H. Takahashi: Contribution of Selected Smoke Constituents to TPM Mutagenic Potencies in Salmonella typhimurium TA98; CORESTA Congress, Smoke Science and Product Technology Groups, Paris, France, 2006, paper SS25.
- 59. Fukushima, T., Y Otsu and H. Takahashi: Contribution of Five Nitrogen-containing Compounds to TPM Mutagenic Potencies in Salmonella typhimurium TA98; CORESTA Congress, Smoke Science and Product Technology Groups, Shanghai, China, 2008, paper SSPT04.
- 60. Wieczorek, R., W. Röper, and E. Kahl: Mutagenicity of Cigarette Smoke Vapour Phase in the AMES Test; CORESTA Joint Meeting Smoke Science and Product Technology Study Groups, Jeju Island, South Korea, 2007, paper SSPT 42.
- 61. Rickert, W.S., A. Trivedi, and W. Wright: Effect of Smoking Condition and Method of Collection on TA98 and TA100 Response to Crude Smoke Condensate (CSC) From Control Cigarettes (Kentucky Reference 1R4F, 1R5F and a Canadian flue-cured monitor); CORESTA Congress, Smoke Science and Product Technology Groups, New Orleans, USA, 2002, paper ST7.
- 62. Röper, W., R. Wieczorek, and M. Intorp: Hoffmann Analytes and Cigarette Smoke in Vitro Toxicity Revis-ited - How Do the Data Compare? CORESTA Congress, Plenary Session, Kyoto, Japan, 2004, paper APSSPT3.
- 63. Breheny, D., M.D. Gaça, I.M. Fearon, G.J. Phillips, S. Faux, and K. Luettich: in Vitro Model Development At British American Tobacco; CORESTA Congress, Smoke Science and Product Technology Groups, Edinburgh, UK, 2010, paper SSPT33.